Wall Street Analysts Think Meta Platforms (META) Is a Good Investment: Is It?
Werte in diesem Artikel
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Meta Platforms (META).Meta Platforms currently has an average brokerage recommendation (ABR) of 1.38, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 52 brokerage firms. An ABR of 1.38 approximates between Strong Buy and Buy.Of the 52 recommendations that derive the current ABR, 43 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 82.7% and 3.9% of all recommendations.Brokerage Recommendation Trends for METACheck price target & stock forecast for Meta Platforms here>>>The ABR suggests buying Meta Platforms, but making an investment decision solely on the basis of this information might not be a good idea. According to several studies, brokerage recommendations have little to no success guiding investors to choose stocks with the most potential for price appreciation.Do you wonder why? As a result of the vested interest of brokerage firms in a stock they cover, their analysts tend to rate it with a strong positive bias. According to our research, brokerage firms assign five "Strong Buy" recommendations for every "Strong Sell" recommendation.This means that the interests of these institutions are not always aligned with those of retail investors, giving little insight into the direction of a stock's future price movement. It would therefore be best to use this information to validate your own analysis or a tool that has proven to be highly effective at predicting stock price movements.With an impressive externally audited track record, our proprietary stock rating tool, the Zacks Rank, which classifies stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), is a reliable indicator of a stock's near -term price performance. So, validating the Zacks Rank with ABR could go a long way in making a profitable investment decision.Zacks Rank Should Not Be Confused With ABRIn spite of the fact that Zacks Rank and ABR both appear on a scale from 1 to 5, they are two completely different measures.The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.On the other hand, earnings estimate revisions are at the core of the Zacks Rank. And empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns.There is also a key difference between the ABR and Zacks Rank when it comes to freshness. When you look at the ABR, it may not be up-to-date. Nonetheless, since brokerage analysts constantly revise their earnings estimates to reflect changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in predicting future stock prices.Is META Worth Investing In?Looking at the earnings estimate revisions for Meta Platforms, the Zacks Consensus Estimate for the current year has increased 0.4% over the past month to $22.68.Analysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for Meta Platforms. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Therefore, the Buy-equivalent ABR for Meta Platforms may serve as a useful guide for investors.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.1% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Meta Platforms, Inc. (META): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Meta Platforms (ex Facebook)
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Meta Platforms (ex Facebook)
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Meta Platforms (ex Facebook)
Analysen zu Meta Platforms (ex Facebook)
Datum | Rating | Analyst | |
---|---|---|---|
10.01.2025 | Meta Platforms (ex Facebook) Buy | UBS AG | |
09.01.2025 | Meta Platforms (ex Facebook) Outperform | Bernstein Research | |
06.01.2025 | Meta Platforms (ex Facebook) Buy | Jefferies & Company Inc. | |
20.12.2024 | Meta Platforms (ex Facebook) Outperform | RBC Capital Markets | |
20.11.2024 | Meta Platforms (ex Facebook) Buy | Jefferies & Company Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
10.01.2025 | Meta Platforms (ex Facebook) Buy | UBS AG | |
09.01.2025 | Meta Platforms (ex Facebook) Outperform | Bernstein Research | |
06.01.2025 | Meta Platforms (ex Facebook) Buy | Jefferies & Company Inc. | |
20.12.2024 | Meta Platforms (ex Facebook) Outperform | RBC Capital Markets | |
20.11.2024 | Meta Platforms (ex Facebook) Buy | Jefferies & Company Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
02.02.2023 | Meta Platforms (ex Facebook) Halten | DZ BANK | |
27.10.2022 | Meta Platforms (ex Facebook) Neutral | JP Morgan Chase & Co. | |
28.07.2022 | Meta Platforms (ex Facebook) Neutral | JP Morgan Chase & Co. | |
21.07.2022 | Meta Platforms (ex Facebook) Neutral | JP Morgan Chase & Co. | |
29.06.2022 | Meta Platforms (ex Facebook) Neutral | JP Morgan Chase & Co. |
Datum | Rating | Analyst | |
---|---|---|---|
12.05.2022 | Meta Platforms (ex Facebook) Hold | HSBC | |
05.12.2019 | Facebook Reduce | HSBC | |
31.01.2019 | Facebook Sell | Pivotal Research Group | |
31.10.2018 | Facebook Sell | Pivotal Research Group | |
12.10.2018 | Facebook Sell | Pivotal Research Group |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Meta Platforms (ex Facebook) nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen